Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SolveBio (acquired by Precision Medicine Group) logo — SolveBio is a digital platform for oncology clinical trials...

SolveBio (acquired by Precision Medicine Group)

SolveBio is a digital platform for oncology clinical trials and translational research.

Founded 2013 1 employees Grant Total: $3.50M Analytics, Biotechnology +1

General Information

Company Name SolveBio (acquired by Precision Medicine Group)
Founded Year 2013
Employees 1
Industries Analytics, Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with SolveBio (acquired by Precision Medicine Group). To contact SolveBio (acquired by Precision Medicine Group), visit solvebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About SolveBio (acquired by Precision Medicine Group)

SolveBio is a contextual knowledge hub with a focus on enabling pharma, biotech, and diagnostic organizations to effectively connect and use external and internal genomic information. The startup, founded in 2013, aims to empower these firms in seamlessly integrating and utilizing genomic data both externally and internally. With a primary focus on analytics and biotechnology, SolveBio received a $1.50M grant investment on 08 January 2018 from the National Institutes of Health. This injection of capital underscores the confidence shown by the NIH in SolveBio's potential to revolutionize the utilization of genomic data in the field.

Taxonomy: genomic data integration, pharmaceutical industry, biotech industry, diagnostic firms, knowledge hub, external data, internal data, contextual information, genomic information, biomedical informatics, precision medicine, biomedical research

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.50M 1
National Institutes of Health
08 Jan 2018
Seed Round Undisclosed 3
Healthy Ventures CSC Upshot Great Oaks
Healthy Ventures, CSC Upshot +1
01 Sep 2015
Seed Round $2.00M 4
Andreessen Horowitz/ a16z SV Angel Max Levchin
Andreessen Horowitz/ a16z, SV Angel +2
13 May 2014

SolveBio (acquired by Precision Medicine Group) Alternatives & Competitors

View All Alternatives
SolveBio (acquired by Precision Medicine Group) vs
xilis
xilis United States

Next generation technologies for precision medicine.

Series A
74 employees
Biotechnology, Health Care
SolveBio (acquired by Precision Medicine Group) vs
Ardais Corporation
Ardais Corporation

Pioneering the integration of human disease into pharmaceutical discovery, advancing biomedical rese...

Series C
Biotechnology, Health Care
SolveBio (acquired by Precision Medicine Group) vs
CTIS, Inc.
CTIS, Inc. United States

Accelerating Clinical Research, Improving Health Outcomes.

128 employees
Analytics, Big Data
View all alternatives

FAQ About SolveBio (acquired by Precision Medicine Group)

SolveBio is a digital platform for oncology clinical trials and translational research.
SolveBio (acquired by Precision Medicine Group) was founded in 2013.
SolveBio (acquired by Precision Medicine Group) operates in Analytics, Biotechnology and Health Care. Its work centres on genomic data integration, pharmaceutical industry, biotech industry and diagnostic firms.
SolveBio (acquired by Precision Medicine Group) has approximately 1 employees.
SolveBio (acquired by Precision Medicine Group) has completed 3 funding rounds, raising a total of $3.50M. The latest funding stage is Grant.
Top alternatives and competitors to SolveBio (acquired by Precision Medicine Group) include xilis, Ardais Corporation, CTIS, Inc., Bainom, Meridien Research. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SolveBio (acquired by Precision Medicine Group) and xilis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SolveBio (acquired by Precision Medicine Group), https://bouncewatch.com/company/solvebio, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes